APA's Practice Guideline for the
Treatment of Patients With Bipolar Disorder, 2nd
Edition, was published in April 2002 (1). Since that time, a number
of controlled treatment studies on aspects of bipolar disorder have
been completed and published or are in press, including studies
of second-generation (atypical) antipsychotics as monotherapy and
as adjunctive treatment (with more traditional mood stabilizers)
for the acute treatment of mania, studies of antiepileptic agents
for the acute treatment of mania, trials for three medications for
the acute treatment of bipolar depression, four monotherapy and
one combination therapy relapse prevention studies, and studies
of psychosocial interventions for maintenance. The evidence from
these studies supports a substantially expanded set of options for
clinicians who treat patients with bipolar disorder. This guideline
watch briefly reviews the most important of the studies. The majority
of the studies were industry supported.